14.07USD+0.82%Mkt Cap: 1.56B USDP/E: —Last update: 2026-06-01
Amylyx Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, engages in the discovery and development of treatment options for neurodegenerative diseases and endocrine conditions in the United States. It provid…
Industry Peers
Drug Manufacturers - Specialty & Generic150.78BSEKP/E 166.4
58.93BTRY—
56.89BEURP/E 22.4
32.78BPLNP/E 21.4
23.20BUSDP/E 20.2
18.39BUSD—
16.21BUSDP/E 24.8
13.00BTRY—
Indicators:|
Key Statistics
Company
Market Cap1.56B USD
Enterprise Value1.32B USD
Revenue (TTM)—
Gross Profit0 USD
Net Income (TTM)-144.74M USD
Revenue/Share—
Last Price14.07 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees136
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-11.33
PEG—
EV/EBITDA-8.32
EV/Revenue—
P/S—
P/B5.83
EPS (TTM)-1.48
EPS (Forward)-1.27
52W Range
4.70567% of range18.61
52W High18.61 USD
52W Low4.705 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-47.41%
ROA-43.51%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-123.34M USD
CapEx (TTM)138.00K USD
FCF Margin—
FCF Yield-4.58%
Net Debt-274.14M USD
Net Debt/EBITDA1.73
Balance Sheet
Debt/Equity0.02
Current Ratio17.85
Quick Ratio17.53
Book Value/Sh2.460 USD
Cash/Share2.516 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)23.40 USD
Target Range19.00 USD – 34.00 USD
# Analysts10
Ownership
Shares Out.111.19M
Float83.53M
Insiders7.92%
Institutions105.09%
Short Interest
Short Ratio12.9d
Short % Float16.89%
Short % Out.13.05%
Shares Short14.51M
Short (prev mo.)14.83M
Technical
SMA 5015.23 (-7.6%)
SMA 20013.65 (+3.1%)
Beta-0.10
S&P 52W Chg27.94%
Avg Vol (30d)942.32K
Avg Vol (10d)928.11K
Technical Indicators
RSI (14)43.3
MACD-0.5359
MACD Signal-0.5661
MACD Hist.+0.0302
BB Upper16.67 USD
BB Middle14.43 USD
BB Lower12.18 USD
BB Width31.08%
ATR (14)0.7224 USD
Vol Ratio (20d)0.24x